CAGRI/SEMA 5MG/5MG – Dual Research Peptide Blend – For Laboratory Use Only

High-Purity Metabolic Synergy Blend

CAGRI/SEMA 5MG/5MG is a research-grade dual peptide blend combining Cagrilintide (amylin analog) and Semaglutide (GLP-1 receptor agonist). This combination is widely studied in laboratory settings for its complementary effects on appetite regulation, metabolic signaling, and energy balance pathways.

By targeting both GLP-1 and amylin receptor systems, this blend provides researchers with a model for investigating multi-pathway metabolic interactions and endocrine signaling synergy.

Product Details

Components:

• Semaglutide – 5mg
• Cagrilintide – 5mg

Total Content: 10mg combined
Purity: ≥98%
Form: Lyophilized Powder
Grade: Research Grade
Storage: Store at -20°C. After reconstitution, refrigerate at 2–8°C and follow laboratory handling protocols.

Research Focus Areas

CAGRI/SEMA is commonly studied in:

• GLP-1 receptor signaling pathways
• Amylin receptor activation and satiety signaling
• Appetite and feeding behavior regulation
• Energy balance and metabolic adaptation
• Glucose metabolism and insulin signaling models
• Endocrine and neuroendocrine pathway interactions
• Body composition and adipose tissue research
• Multi-pathway incretin system studies

Potential Research Applications

Researchers may utilize this blend in studies involving:

• Combination incretin/amylin pathway analysis
• Appetite suppression and satiety mechanism research
• Metabolic rate and energy expenditure models
• Obesity and metabolic disorder research frameworks
• Hormonal signaling interaction studies
• Glucose homeostasis and nutrient sensing research
• Comparative dual-pathway efficacy modeling

Key Features

✔ Dual mechanism: GLP-1 + Amylin analog system
✔ High-purity research-grade peptides (≥98%)
✔ Synergistic metabolic signaling model
✔ Lyophilized for long-term stability
✔ Ideal for advanced endocrine and metabolic research

Scientific Significance

The CAGRI/SEMA combination is used in research exploring multi-receptor metabolic regulation. Its dual-pathway design allows investigators to study how GLP-1 and amylin signaling interact to influence appetite, energy utilization, and metabolic homeostasis in controlled laboratory environments.

Research Use Disclaimer

For laboratory research use only. Not for human consumption. Not intended for medical, therapeutic, veterinary, or diagnostic use. This product is supplied exclusively for scientific research purposes.